Javascript must be enabled to continue!
Comparison of Pharmacoinvasive PCI and Delayed Regular PCI in ST-Elevation Myocardial Infarction Patients with Short-Term Hospital Outcomes
View through CrossRef
Background: Primary PCI remains a challenge due to the factors like few PCI performing centres, financial issues, delay in timely transfer to such centres. Thus, thrombolytic therapy continues to be the most common reperfusion modality in our setup. The optimal treatment after thrombolysis is still unclear. Objective: To comparison between pharmacoinvasive PCI and delayed routine PCI in ST-elevation myocardial infarction patients with short-term hospital outcomes. Materials and Method: This was a prospective observational comparative study which was conducted in Department of Cardiology, Northeast Medical College, Sylhet, We enrolled total of 120 thrombolysed ST- segment elevation myocardial infarction (STEMI) patients that underwent PCI after considering inclusion and exclusion criteria. Depending on the timing of PCI performed after thrombolysis, two groups were divided as pharmacoinvasive PCI group (refers as PCI performed within 3-24 hrs after thrombolytic therapy) and delayed routine PCI group (refers to PCI performed >24 h to 2 weeks after thrombolytic therapy). In-hospital MACEs (Myocardial re-infarction, target vessel revascularization, heart failure, stroke, and cardiac death) were observed and recorded. All patients were followed up for a period of 30 days. Then findings of 2 groups were compared. Result: In-hospital outcome comparing two groups: incidence of cardiac re-infarction, target vessel revascularization, heart failure and cardiac death were higher in delayed routine PCI group than pharmacoinvasive PCI group (8.2% vs 4.0%, 4.1% vs 2.0%, 10.2% vs 6.0% and 4.1% vs 2.0) and p value (0.329, 0.492, 0.346 and 0.492) respectively, which did not show statistically significant difference. Conclusion: Even after 24 h of thrombolytic treatment in STEMI patients, delayed routine PCI can be performed with comparable outcome to that of PCI within 24 h.
SASPR Edu International Pvt. Ltd
Title: Comparison of Pharmacoinvasive PCI and Delayed Regular PCI in ST-Elevation Myocardial Infarction Patients with Short-Term Hospital Outcomes
Description:
Background: Primary PCI remains a challenge due to the factors like few PCI performing centres, financial issues, delay in timely transfer to such centres.
Thus, thrombolytic therapy continues to be the most common reperfusion modality in our setup.
The optimal treatment after thrombolysis is still unclear.
Objective: To comparison between pharmacoinvasive PCI and delayed routine PCI in ST-elevation myocardial infarction patients with short-term hospital outcomes.
Materials and Method: This was a prospective observational comparative study which was conducted in Department of Cardiology, Northeast Medical College, Sylhet, We enrolled total of 120 thrombolysed ST- segment elevation myocardial infarction (STEMI) patients that underwent PCI after considering inclusion and exclusion criteria.
Depending on the timing of PCI performed after thrombolysis, two groups were divided as pharmacoinvasive PCI group (refers as PCI performed within 3-24 hrs after thrombolytic therapy) and delayed routine PCI group (refers to PCI performed >24 h to 2 weeks after thrombolytic therapy).
In-hospital MACEs (Myocardial re-infarction, target vessel revascularization, heart failure, stroke, and cardiac death) were observed and recorded.
All patients were followed up for a period of 30 days.
Then findings of 2 groups were compared.
Result: In-hospital outcome comparing two groups: incidence of cardiac re-infarction, target vessel revascularization, heart failure and cardiac death were higher in delayed routine PCI group than pharmacoinvasive PCI group (8.
2% vs 4.
0%, 4.
1% vs 2.
0%, 10.
2% vs 6.
0% and 4.
1% vs 2.
0) and p value (0.
329, 0.
492, 0.
346 and 0.
492) respectively, which did not show statistically significant difference.
Conclusion: Even after 24 h of thrombolytic treatment in STEMI patients, delayed routine PCI can be performed with comparable outcome to that of PCI within 24 h.
Related Results
SAFETY AND EFFICACY OF THROMBOLYSIS FOLLOWED BY EARLY PERCUTANEOUS CORONARY INTERVENTION VIA TRANSRADIAL ARTERY APPROACH IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
SAFETY AND EFFICACY OF THROMBOLYSIS FOLLOWED BY EARLY PERCUTANEOUS CORONARY INTERVENTION VIA TRANSRADIAL ARTERY APPROACH IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Objectives
This study was to investigate the safety and efficacy of thrombolysis followed by early PCI via transradial artery approach in patients with ST-segment...
Predictors of Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Sana’a City-Yemen (Single center study)
Predictors of Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Sana’a City-Yemen (Single center study)
Background: Recently, many hospitals in Yemen have been started using Percutaneous Coronary Intervention (PCI) procedure for treatment coronary artery disease (CAD), including Dr. ...
Possible effects and changes of myocardial injury markers in percutaneous coronary intervention
Possible effects and changes of myocardial injury markers in percutaneous coronary intervention
Objective
Percutaneous Coronary Intervention (PCI) is a technique of cardiac intervention treatment in revascularisation of coronary vessel. The use of PCI in pat...
Hemoglobin Level as a Predictor of Major Adverse Cardiovascular Events and Short-term Outcomes in Stemi Patient Treated with Pharmacoinvasive Strategy versus Primary PCI
Hemoglobin Level as a Predictor of Major Adverse Cardiovascular Events and Short-term Outcomes in Stemi Patient Treated with Pharmacoinvasive Strategy versus Primary PCI
Background: Anaemia is prevalent among cases with acute coronary syndrome (ACS) and has been linked to poor clinical prognosis. Guidelines for cases with ST-segment elevation myoca...
e0540 Efficacy and safety of tirofiban-assisted Delayed PCI in Patients with ST-segment elavation myocardial infarction
e0540 Efficacy and safety of tirofiban-assisted Delayed PCI in Patients with ST-segment elavation myocardial infarction
Objective
To compare the outcomes of IIb/IIIa antagonist assisted PCI within 12–72 h of onset with that of selective PCI within 7–10 days in STEMI patients.
...
Abstract P338: Differences in Costs, Length of Stay and Mortality for Myocardial Infarction and Related Disorders in Non Federal Hospitals
Abstract P338: Differences in Costs, Length of Stay and Mortality for Myocardial Infarction and Related Disorders in Non Federal Hospitals
BACKGROUND:
Validated estimates of costs, length of stay, and mortality rates are necessary for the treatment and prevention of acute myocardial infarction in patient a...
Predictors of heart failure at 3-month follow-up in patients undergoing pharmacoinvasive percutaneous coronary intervention for anterior wall STEMI: A cross-sectional study.
Predictors of heart failure at 3-month follow-up in patients undergoing pharmacoinvasive percutaneous coronary intervention for anterior wall STEMI: A cross-sectional study.
Background
Anterior wall ST-elevation myocardial infarction (STEMI) often leads to left ventricular (LV) dysfunction and clinical heart failure despite timely reperfusion. The phar...
EFFECTS OF STATIN LOADING BEFORE PRIMARY PCI ON CORONARY ENDOTHELIAL FUNCTION AND INFLAMMATION
EFFECTS OF STATIN LOADING BEFORE PRIMARY PCI ON CORONARY ENDOTHELIAL FUNCTION AND INFLAMMATION
Objectives
The Novel approaches for preventing or limiting events (NAPLIES) and The Atorvastatin for Reduction of Myocardial Damage during Angioplasty (ARMYDA) st...

